Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Noncompliance with required follow-up visits and properly taking medications is a serious issue. Dr. Blevins tackles this problem with real clinical examples in this brief podcast.
From the PWN library, we highlight our engaging podcast series “Musings,” covering various exciting subjects directly from Dr. Blevins’ desk. From lab result targets explaining how lab tests work, to what makes aiming at and
Listen to this informative podcast with Ren Renwick, CEO of the Pituitary Foundation in the United Kindom. The foundation is a leading volunteer organization providing a variety of resources and support functions for people with pituitary disease.
Continuing our recent coverage of brain fog, Dr. Blevins and I discussed a few examples from his clinical practice and personal experiences with the condition. We also cover a fascinating case from his clinic about a patient with an empty sella incidental finding and residual disease.
With today’s podcasts from this week’s live-talk show, Dr. Blevins recaps our content dedicated to Global Cushing’s month with a talk about two fascinating recent Cushing cases from his practice. He also touches on some very interesting caveats about thyroid hormone replacement.
Listen to this fascinating discussion of adrenal Cushing’s or hypercortisolism as Dr. Lewis Blevins walks us through the disease’s characteristics, biochemistry, and treatment options. In the talk, he focuses on different conditions, including adrenal adenomas, adrenal cancer, adrenal hyperplasia, and other related diseases like Carney Complex and McCune-Albright syndrome.
Join us as we welcome marriage and family therapist Linda Rio for a fascinating discussion on how pituitary disease, or any chronic disease, manifests itself mentally and emotionally.
Meet Laura Cheng. Laura is a nurse. She has acromegaly. She works as a clinical nurse and is currently enrolled in the endocrine program at Duke University.
This week’s Live-talk offers critical knowledge that people affected with pituitary and endocrine diseases need to know to ensure they receive proper treatment. Dr. Sylvia Asa, a pioneer in endocrine and pituitary tumor pathology, talks with Dr. Lewis Blevins about her work in the field and the reclassification of pituitary adenomas to Pituitary Neuroendocrine Tumors, or PitNets.
In our first live-talk session of 2023, we focus on critical topics, including insurance delay trends affecting pituitary medical practices, interesting clinical cases we can learn from, where telemedicine is going after the Covid era, and more commentary from the subjects we covered in our recent “briefing and insights” article.
Today we present an excellent discussion with Dr. Alan Krasner, Chief Medical Officer for Crinetics Pharmaceuticals. Dr. Krasner speaks to PWN about two very important drugs currently under development.
The ongoing debates and nomenclature change and reclassification are apparently over, and adenomas are now referred to as Pit-Net’s (pituitary neuroendocrine tumors). Is this good, bad, or indifferent?